CDK4/6 inhibitors are essential for preventing cancer cell growth by blocking the activity of cyclin-dependent kinases 4 and 6, particularly in the treatment of advanced ER+ and HER2-negative breast cancer86. This evidence concerns the gene CDK4 and cancer.